WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a large growth in short interest in May. As of May 29th, there was short interest totaling 155,338 shares, a growth of 1,225.0% from the May 14th total of 11,724 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 479,488 shares, the short-interest ratio is presently 0.3 days.

WuXi Biologics (Cayman) Price Performance

Shares of OTCMKTS WXXWY traded down $0.06 during mid-day trading on Wednesday, hitting $7.54. The company had a trading volume of 40,295 shares, compared to its average volume of 74,951. The firm has a 50-day simple moving average of $8.63 and a two-hundred day simple moving average of $8.95. WuXi Biologics has a one year low of $6.02 and a one year high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.